The fully linked HTML version of this article has now been published.
JCS ePress
online publication date 11 Oct 2005
doi: 10.1242/jcs.02610
Research Article
The transmembrane domain is essential for the microtubular trafficking of membrane type-1 matrix metalloproteinase (MT1-MMP)
Albert G. Remacle,
Dmitri V. Rozanov,
Peter C. Baciu,
Alexei V. Chekanov,
Vladislav S. Golubkov,
and
Alex Y. Strongin*
* Author for correspondence (e-mail: strongin{at}burnham.org)
Membrane type-1 matrix metalloproteinase (MT1-MMP) degrades the extracellular matrix, initiates the activation pathway of soluble MMPs and regulates the functionality of cell adhesion signaling receptors, thus playing an important role in many cell functions. Intracellular transport mechanisms, currently incompletely understood, regulate the presentation of MT1-MMP at the cell surface. We have focused our efforts on identifying these mechanisms. To understand the transport of MT1-MMP across the cell, we used substitution and deletion mutants, the trafficking of which was examined using antibody uptake and Chariot delivery experiments. Our experiments have demonstrated that the microtubulin cytoskeleton and the centrosomes (the microtubulin cytoskeleton-organizing centers) are essential for the trafficking and the internalization of MT1-MMP. We determined that after reaching the plasma membrane, MT1-MMP is internalized in the Rab-4-positive recycling endosomes and the Rab-11-positive pericentrosomal recycling endosomes. The microtubular trafficking causes the protease to accumulate in the pericentrosomal region of the cell. We believe that the presence of the transmembrane domain is required for the microtubular vesicular trafficking of MT1-MMP because the soluble mutants are not presented at the cell surface and they are not delivered to the centrosomes. The observed transport mechanisms provide a vehicle for the intracellular targets and, accordingly, for an intracellular cleavage function of MT1-MMP in malignant cells, which routinely overexpress this protease.
CiteULike 
Complore 
Connotea 
Del.icio.us 
Digg 
Reddit 
Technorati 
Twitter What's this?
This article has been cited by other articles:
|
|
|
|
 
R. Poincloux, F. Lizarraga, and P. Chavrier
Matrix invasion by tumour cells: a focus on MT1-MMP trafficking to invadopodia
J. Cell Sci.,
September 1, 2009;
122(17):
3015 - 3024.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
M. D. Bass, M. R. Morgan, and M. J. Humphries
Syndecans Shed Their Reputation as Inert Molecules
Sci. Signal.,
March 31, 2009;
2(64):
pe18 - pe18.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
M. Ouyang, S. Lu, X.-Y. Li, J. Xu, J. Seong, B. N. G. Giepmans, J. Y.-J. Shyy, S. J. Weiss, and Y. Wang
Visualization of Polarized Membrane Type 1 Matrix Metalloproteinase Activity in Live Cells by Fluorescence Resonance Energy Transfer Imaging
J. Biol. Chem.,
June 20, 2008;
283(25):
17740 - 17748.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
F. G. Spinale
Myocardial Matrix Remodeling and the Matrix Metalloproteinases: Influence on Cardiac Form and Function
Physiol Rev,
October 1, 2007;
87(4):
1285 - 1342.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
L. S. Spruill, A. S. Lowry, R. E. Stroud, C. E. Squires, I. M. Mains, E. C. Flack, C. Beck, J. S. Ikonomidis, A. J. Crumbley, P. J. McDermott, et al.
Membrane-type-1 matrix metalloproteinase transcription and translation in myocardial fibroblasts from patients with normal left ventricular function and from patients with cardiomyopathy
Am J Physiol Cell Physiol,
October 1, 2007;
293(4):
C1362 - C1373.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
A. Knoblauch, C. Will, G. Goncharenko, S. Ludwig, and V. Wixler
The binding of Mss4 to {alpha}-integrin subunits regulates matrix metalloproteinase activation and fibronectin remodeling
FASEB J,
February 1, 2007;
21(2):
497 - 510.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
V. S. Golubkov, A. V. Chekanov, A. Y. Savinov, D. V. Rozanov, N. V. Golubkova, and A. Y. Strongin
Membrane Type-1 Matrix Metalloproteinase Confers Aneuploidy and Tumorigenicity on Mammary Epithelial Cells
Cancer Res.,
November 1, 2006;
66(21):
10460 - 10465.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
A. G. Remacle, A. V. Chekanov, V. S. Golubkov, A. Y. Savinov, D. V. Rozanov, and A. Y. Strongin
O-Glycosylation Regulates Autolysis of Cellular Membrane Type-1 Matrix Metalloproteinase (MT1-MMP)
J. Biol. Chem.,
June 23, 2006;
281(25):
16897 - 16905.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
V. Chabottaux, N. E. Sounni, C. J. Pennington, W. R. English, F. van den Brule, S. Blacher, C. Gilles, C. Munaut, E. Maquoi, C. Lopez-Otin, et al.
Membrane-type 4 matrix metalloproteinase promotes breast cancer growth and metastases.
Cancer Res.,
May 15, 2006;
66(10):
5165 - 5172.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
V. S. Golubkov, A. V. Chekanov, S. J. Doxsey, and A. Y. Strongin
Centrosomal Pericentrin Is a Direct Cleavage Target of Membrane Type-1 Matrix Metalloproteinase in Humans but Not in Mice: POTENTIAL IMPLICATIONS FOR TUMORIGENESIS
J. Biol. Chem.,
December 23, 2005;
280(51):
42237 - 42241.
[Abstract]
[Full Text]
[PDF]
|
|
|
© The Company of Biologists Ltd 2005
